Rockwell Medical (RMTI) Tax Provisions (2011 - 2016)
Rockwell Medical's (RMTI) quarterly Tax Provisions came in at -$7.0 million in Q4 2016, down 1830.41% on a QoQ basis from $404527.0 in Q1 2016.
Rockwell Medical (RMTI) Tax Provisions (2011 - 2016) Analysis & Trends
Rockwell Medical (RMTI) has 3 years of Tax Provisions data on file, last reported at -$7.0 million in Q4 2016.
- Quarterly Tax Provisions changed N/A year-over-year to -$7.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$6.6 million (changed N/A YoY) and the FY2017 annual result came in at -$8.8 million, down 33.63% from the prior year.
- Tax Provisions declined to -$7.0 million in Q4 2016, from $404527.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $404527.0 in Q1 2016 to a low of -$16.6 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -7.00 Mn |
| Mar 31, 2016 | 404,527.00 |
| Dec 31, 2013 | -16.58 Mn |
| Dec 31, 2011 | 47.00 |
| Sep 30, 2011 | 1,958.00 |